Unlock instant, AI-driven research and patent intelligence for your innovation.

CSF1R inhibitor intermediate and preparation method thereof

A technology of inhibitors and intermediates, applied in the field of preparation of intermediates of CSF1R inhibitors

Active Publication Date: 2020-08-11
XIAMEN BIOTIME BIOTECHNOLOGY CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The combined drug project of CSF1R inhibitors and immune checkpoint inhibitors is still in the early clinical stage, and no compound has entered clinical application in China

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CSF1R inhibitor intermediate and preparation method thereof
  • CSF1R inhibitor intermediate and preparation method thereof
  • CSF1R inhibitor intermediate and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0063] Preparation of compound INT-1:

[0064]

[0065] At 0°C, cesium carbonate (241.0g, 0.74mol) and 5-bromo-2-nitropyridine (100.0g, 0.49mol) were sequentially added to a solution of 2-chloro-4-hydroxypyridine (70.2g, 0.54mol) in N,N-dimethylformamide (1.5L) solution. The reaction solution was stirred at 80° C. for 24 hours. After the reaction solution was filtered, the filtrate was concentrated under reduced pressure to remove most of the solvent, and diluted with ethyl acetate (2L); the organic layer was washed with water (2Lx2) and saturated brine (1Lx2) successively, and dried over anhydrous magnesium sulfate. The filtrate was concentrated under reduced pressure to obtain a crude product, which was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 100:1 to 1:1) to obtain INT-1a (43.5 g, yield: 31.9%) as a yellow oil. 1 H NMR (DMSO-d 6 ,400MHz)δ8.64(s,1H),8.47-8.40(m,2H),8.14–8.02(m,1H),7.39(s,1H),7.25(s,1H); MS:252.0[M+ H]+.

[0066]...

Embodiment 1

[0099] Embodiment 1: the preparation of compound 1

[0100]

[0101] At 0°C, a solution of triphosgene (95 mg, 0.32 mmol) pre-dissolved in tetrahydrofuran (2 mL) was slowly added dropwise to compound INT-1 (107 mg, 0.40 mmol) and triethylamine (222 μL, 1.60 mmol) in tetrahydrofuran (5 mL) solution. The reaction solution was gradually raised to room temperature with stirring, and continued stirring at room temperature for 1 hour. LC / MS showed that the starting material was completely consumed, and the reaction solution was concentrated under reduced pressure, and water (15 mL) and a mixed solution of dichloromethane and methanol (15 mL, v / v=10 / 1) were added. The organic phase was washed with saturated brine (15 mLx2), and dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to obtain compound 1a, which was directly used in the next step without isolation.

[0102] Sodium hydrogen (60% w / w in kerosene; 80 mg, 2.0 mmol) was added to a solu...

Embodiment 2

[0113] Embodiment 2: the preparation of compound 11

[0114]

[0115] Starting from compound INT-1, following the synthesis of compound 1, a white solid 11a was obtained. 1HNMR (DMSO-d 6,500MHz)δ11.04(s,1H),8.37(d,J=5.7Hz,1H),8.27(d,J=3.0Hz,1H),8.25(s,1H),8.08(d,J=9.0 Hz,1H),7.96(s,1H),7.76(dd,J=9.0,3.0Hz,1H),7.23(d,J=3.0Hz,1H),6.69(dd,J=5.7,3.0Hz,1H ),3.84(s,3H),3.79(t,J=7.1Hz,4H),3.07-2.92(m,2H),2.03(t,J=7.1Hz,2H),1.65-1.53(m,4H) , 1.40 (s, 9H); MS: 548.3 [M+H]+.

[0116] To a solution of compound 11a (350 mg, 0.64 mmol) in dichloromethane (6 mL) was added hydrochloric acid (4Min dioxane, 0.8 mL). After the reaction solution was stirred at room temperature for 4 hours, LC / MS showed that the starting material had been consumed. The reaction solution was concentrated under reduced pressure to obtain 11 as a white solid. 1 H NMR (500MHz, DMSO-d 6 )δ11.05(s,1H),8.78(s,1H),8.56(d,J=6.0Hz,1H),8.46(s,1H),8.41(s,1H),8.14(d,J=9.0 Hz, 1H), 7.91(d, J=9.0Hz, 1H), 7.75(s, 1H),...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of a CSF1R inhibitor intermediate with antitumor activity. The CSF1R inhibitor intermediate has a structure as shown in a formula I, and the CSF1R inhibitor intermediate prepared by the preparation method has high inhibitory activity on CSF1R.

Description

[0001] This application is a divisional application, the Chinese application number of the parent case is: 201980005226.1, the international application number is PCT / CN2019 / 088221, and the filing date is May 24, 2019. [0002] The present invention claims the priority of the Chinese patent application CN201810559228.2, and the contents described in the specification, drawings and claims of the priority document are incorporated into the specification of the present invention in its entirety and are regarded as part of the original description of the specification of the present invention. The applicant further declares that the applicant has the right to amend the description and claims of the present invention based on the priority document. technical field [0003] The invention relates to heterocyclic compounds, in particular to a preparation method of a highly active CSF1R inhibitor intermediate. Background technique [0004] CSF1R (colony stimulating factor 1 receptor)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D209/54C07D491/107C07C303/28C07C309/73C07D307/24C07D309/08
CPCC07D209/54C07D401/14C07D413/14C07D417/14A61K31/4439A61K31/497A61P35/00A61P37/00C07D491/107C07D471/10C07D487/10
Inventor 刘世峰俞智勇庞伟王骥陈鹏
Owner XIAMEN BIOTIME BIOTECHNOLOGY CO LTD